Skip to content
Research Article Open access CC BY 4.0

Treatment with CSE-1034 (Elores™) in the Management of Community Acquired Pneumonia Due to Multi Drug Resistant Pseudomonas aeruginosa

Atulya Atreja

International Journal of TROPICAL DISEASE & Health · pp. 1–4 · Published 14 Dec 2016

10.9734/IJTDH/2016/28887

Abstract

Introduction: Community acquired pneumonia (CAP) is one of the important cause of mortality and morbidity. CAP is defined as an infection of the lung parenchyma that is not acquired in a hospital, long-term care facility, or other recent contact with the health care system. Frequently, Pseudomonas aeruginosa (P. aeruginosa) is resistant to most antibiotics. This resistance is one of the main barriers in bacterial eradication and clinical cure of Pseudomonas infection. This delay in management of MDR P. aeruginosa with appropriate antibiotics, can lead to increased mortality and morbidity. Case Presentation: Here we discuss a case of a CAP due to P. aeruginosa which clinically didn’t respond to piperacillin-tazobactam & meropenem and was resistant to both classes of antibiotics. This was successfully treated with CSE-1034 (Ceftriaxone/Sulbactam/Disodium-edetate). Conclusion: CSE-1034 (Elores™) proved to be safe and efficacious in treatment of a hospitalized patient with CAP due to MDR P. aeruginosa.

MDR Elores™ CAP Pseudomonas aeruginosa Disodium-edetate CSE-1034.

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.